IPBC Asia; cannabis innovation; Nokia beats Oppo; Continental/Atlantic settlement; Qualcomm success; plus much more | So Good News


We’ve covered the last seven days at IAM – and everything you need to know from the global IP market to prepare for the start of another busy week.

A long read

How to Successfully Manage “Commercial Reasonable Effort” Obligations in IP Agreements in the Courtroom. Read more here

MONDAY October 31

Leading the new Industrial Patent Quality Charter, Siemens’ IP chief urges the European Patent Office to move closer to quality rather than efficiency. Read more here

IP professionals from around the world gathered at The Westin Tokyo for a much-anticipated catch-up at the first IPBC Asia Welcome Reception since 2019. Read more here.

Could Two Federal Circuits’ ‘Inventive Concept’ Decisions Reduce Dismissal Claims? Read more here

TUESDAY 01 November

Corning IP director Anjanette Lecher reflects on applying a diversity and inclusion lens to intellectual property. Read more here

IP Funding, Monetization and more on Day 1 of IPBC Asia 2022 center takes place. Read more here

Five things to know as cannabis innovation and patenting rocket. Read more here

Britain’s High Court has refused to hear Oppo’s appeal over whether the UK case or the Chinese case should prevail in its global patent battle with Nokia. Read more here

WEDNESDAY 02 November

UPC, SEP arbitration and India are among the main issues of the last day of IPBC Asia 2022. Read more here

WIPO Patent Chief Lisa Jorgenson on SEPs, patent quality and the future. Read more here

THURSDAY 03 November

When Frans Brevets folded, its CEO told IAM that public sector ties were hampering monetization efforts. Read more here

KPN has scored points in the US lawsuit against Ericsson, but some issues remain. Read more here

Continental agrees to settlement with Atlantic IP over radar module patent. Read more here

FRIDAY 04 November

InterDigital CEO welcomes Apple deal, but firm not yet committed to Avanci 5G program. Read more here

Behzad Khosrowshahi, CEO of DRI Healthcare Trust, says drug royalty agreements help big pharma overcome patent cliffs. Read more here

Qualcomm is focusing on new licensing markets as handset sales decline. Read more here

SATURDAY 05 November

Communicating changes using the rulemaking process at the USPTO, rather than relying on precedential decisions, may take longer, but is a much more efficient and reliable approach. Read more here


Source link